)
Pyxis Oncology (PYXS) investor relations material
Pyxis Oncology Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for June 15, 2026, to be held virtually for stockholders of record as of April 20, 2026.
Proxy materials, including the Notice of Meeting, Proxy Statement, and Annual Report on Form 10-K, are available online, with paper copies available upon request.
Voting matters and shareholder proposals
Election of three Class II directors: Thomas Civik, Freda Lewis-Hall, M.D., and Michael A. Metzger.
Ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Other business may be transacted as properly brought before the meeting or any adjournment.
Board of directors and corporate governance
Board recommends a vote in favor of the election of the three named Class II directors.
- Stockholders will vote on director elections and auditor ratification, with a focus on governance and ESG.PYXS
Proxy filing30 Apr 2026 - MICVO delivers high response rates in R/M HNSCC with promising safety and ongoing clinical progress.PYXS
Corporate presentation24 Mar 2026 - Strong clinical progress and financial stability with pivotal MICVO data expected in 2026.PYXS
Q4 202523 Mar 2026 - Lead ADC program shows strong clinical momentum and safety, with pivotal data expected this fall.PYXS
Morgan Stanley 22nd Annual Global Healthcare Conference21 Jan 2026 - PYX-201 and PYX-106 advance in clinical trials, with key data and strategic decisions expected by year-end.PYXS
H.C. Wainwright 26th Annual Global Investment Conference21 Jan 2026 - 50% ORR in head and neck cancer and 26% ORR across six tumor types with strong safety.PYXS
Status Update13 Jan 2026 - PYX-201 demonstrated robust, durable responses in head and neck cancer, with key data expected soon.PYXS
Leerink Global Healthcare Conference 202526 Dec 2025 - MICVO demonstrates promising efficacy and safety in head and neck cancer, with key data expected soon.PYXS
Cantor Global Healthcare Conference 202522 Dec 2025 - 46% ORR for monotherapy and 71% for combo, with strong safety and FDA-aligned pivotal trials.PYXS
Study Update18 Dec 2025
Next Pyxis Oncology earnings date
Next Pyxis Oncology earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)